IN VERITAS – The BayneLaw Advantage
  1. Home
  2.  → 
  3. 2020
  4.  → April

Month: April 2020

FDA releases guidance for industry on notifying the agency of permanent discontinuance or interruption in manufacturing under section 506C of the FD&C Act*

The U.S. Food and Drug Administration has issued a guidance, “Notifying FDA of a Permanent Discontinuance or Interruption in Manufacturing Under Section 506C of the FD&C Act.” Due to the COVID-19 pandemic, FDA has been closely monitoring the medical product supply...